Treatment with Humanized Selective CD19CAR-T Cells Shows Efficacy in Highly Treated B-ALL Patients Who Have Relapsed after Receiving Murine-Based CD19CAR-T Therapies
人源化选择性 CD19CAR-T 细胞治疗对接受鼠源 CD19CAR-T 疗法后复发的 B-ALL 患者有疗效
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-19-0916
Yu Zhao #, Zhongfeng Liu #, Xuan Wang #, Huantong Wu, Jianping Zhang, Junfang Yang, Fayou Zhang, Lining Liu, Jiafu Long, Peihua Lu, Zhiguo Chen
